May 07, 2021
Article
Initial data from a phase 2 study showed that a single 50 µg dose of COVID-19 vaccines mRNA-1273 or mRNA-1273.351 given as a booster to individuals who were previously vaccinated increased their neutralizing antibody titer responses against SARS-CoV-2.
Obstacles such as COVID-19 vaccine rollout disparities, vaccine hesitancy, and continuous virus mutation could make herd immunity impossible.
The alliance between pharmaceutical partners and government organizations signals the possibilities of shared resources in meeting global crises.
The companies have also submitted an application to expand the current EUA for the COVID-19 vaccine to include individuals 12 to 15 years of age.
May 06, 2021
Video
Although pharmacists have largely relied on patients coming into their facility, they should begin going out into the community to build trust in COVID-19 vaccines.
May 05, 2021
Idaho State University partners with the Idaho Immunization Coalition to effectively and safely vaccinate patients against influenza.
IQVIA researchers saw a sharp uptick in medication usage shortly before the COVID-19 pandemic began, followed by a steep fall in the first few months of the pandemic.
The AHA released a report to provide guidance about CVST, TTS, and VITT after receiving the COVID-19 vaccine.
When looking at the COVID-19 variants, it is increasingly necessary to assess them in terms of the mutations embedded in the variants themselves.
Although young women were the original targets of human papillomavirus vaccine outreach after its approval in 2006, the increasing rates oropharyngeal cancer has made vaccination for young men even more important.
